FCSC—Elimer Piros of Rodman forecasts $1B of peak sales for laViv, but I’ll be shocked if laViv ever sells more than 2% of that. I mention this for all of the devoted Rodman fans on this board :- )
p.s. FCSC is down 22% since obtaining FDA approval Wednesday morning.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”